DK1041896T3 - Fedtblanding - Google Patents
FedtblandingInfo
- Publication number
- DK1041896T3 DK1041896T3 DK98966662T DK98966662T DK1041896T3 DK 1041896 T3 DK1041896 T3 DK 1041896T3 DK 98966662 T DK98966662 T DK 98966662T DK 98966662 T DK98966662 T DK 98966662T DK 1041896 T3 DK1041896 T3 DK 1041896T3
- Authority
- DK
- Denmark
- Prior art keywords
- fatty acids
- fat blend
- linolenic
- gamma
- eicosapentaenoic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000019197 fats Nutrition 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 abstract 2
- 235000005911 diet Nutrition 0.000 abstract 2
- 230000000378 dietary effect Effects 0.000 abstract 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 230000002366 lipolytic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19757414A DE19757414A1 (de) | 1997-12-23 | 1997-12-23 | Fettmischung |
PCT/EP1998/008409 WO1999033355A2 (fr) | 1997-12-23 | 1998-12-22 | Melange de corps gras |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1041896T3 true DK1041896T3 (da) | 2002-06-17 |
Family
ID=7853100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98966662T DK1041896T3 (da) | 1997-12-23 | 1998-12-22 | Fedtblanding |
Country Status (15)
Country | Link |
---|---|
US (1) | US7045143B1 (fr) |
EP (1) | EP1041896B1 (fr) |
JP (1) | JP2001526908A (fr) |
CN (1) | CN1091363C (fr) |
AT (1) | ATE213391T1 (fr) |
AU (1) | AU758079B2 (fr) |
BR (1) | BR9814467A (fr) |
CA (1) | CA2316298C (fr) |
DE (2) | DE19757414A1 (fr) |
DK (1) | DK1041896T3 (fr) |
ES (1) | ES2173673T3 (fr) |
HK (1) | HK1033541A1 (fr) |
NO (1) | NO316302B1 (fr) |
NZ (1) | NZ505608A (fr) |
WO (1) | WO1999033355A2 (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
DE19914104A1 (de) * | 1999-03-23 | 2000-09-28 | Siegfried Seifert | Verfahren zur Verbesserung der körperlichen Erscheinung eines Menschen unter Verabreichung einer Fett-Eiweiß-Diät |
US6340705B1 (en) * | 1999-09-10 | 2002-01-22 | Monsanto Technology, Llc | Use of α-linolenic acid metabolites for treatment or prevention of cancer |
WO2001024812A1 (fr) * | 1999-10-06 | 2001-04-12 | N.V. Nutricia | UTILISATION DU FACTEUR DE CROISSANCE TRANSFORMANT β ET DE FACTEURS DE CROISSANCE POUR LE TRAITEMENT ET LA PREVENTION D'UNE MALADIE DE LA MUQUEUSE INTESTINALE |
GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
CA2689808A1 (fr) * | 2001-05-14 | 2002-11-21 | Martek Biosciences Corporation | Production et utilisation d'une fraction polaire riche en lipides contenant l'acide stearidonique et l'acide gamma-linolenique extraits de graines et de microorganismes |
WO2002092779A2 (fr) * | 2001-05-17 | 2002-11-21 | Pilot Therapeutics, Inc. | Procede d'enrichissement de tissus dans des acides gras polyinsatures a chaine longue |
US7163960B2 (en) | 2002-03-08 | 2007-01-16 | Monsanto Technology L.L.C. | Treatment and prevention of inflammatory disorders |
DE10254584A1 (de) * | 2002-11-22 | 2004-06-09 | HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie | Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker |
DE10361667A1 (de) * | 2003-12-30 | 2005-07-28 | Omega For Life Gmbh | Neuartige Fettpulver |
EP1723951A1 (fr) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Supplément nutritionnel avec des oligosaccharides pour une catégorie de patients avec HIV |
US20080108548A1 (en) * | 2004-11-12 | 2008-05-08 | N.V. Nutricia | Food Composition For Rapidly Attenuating Inflammatory Responses |
US7893106B2 (en) * | 2004-11-19 | 2011-02-22 | Martek Biosciences, Corporation | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same |
US20090318394A1 (en) * | 2004-11-19 | 2009-12-24 | Julie Nauroth | Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
US7884131B2 (en) | 2004-11-19 | 2011-02-08 | Martek Biosciences, Corporation | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
WO2007063143A1 (fr) * | 2005-11-30 | 2007-06-07 | Katry Inversiones, S.L. | Melange de lipides utilise pour preparer un produit destine a l'administration enterale ou orale |
ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
WO2007090162A2 (fr) * | 2006-01-31 | 2007-08-09 | Martek Biosciences Corporation | OXYLIPINES D'ACIDE STÉARIDONIQUE ET D'ACIDEγ-LINOLÉNIQUE ET PROCÉDÉS DE FABRICATION ET D'UTILISATION |
CN101466270A (zh) * | 2006-04-11 | 2009-06-24 | 马泰克生物科学公司 | 包含长链多不饱和脂肪酸的食品及其制备方法 |
GB0612671D0 (en) * | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
US20080089981A1 (en) * | 2006-10-17 | 2008-04-17 | N.V. Nutricia | Ketogenic diet |
CA2567879C (fr) * | 2006-11-14 | 2013-03-26 | Thomas Greither | Compositions d'huile alimentaire nutritive et methodes pour les produire |
GB2444896B (en) * | 2006-12-18 | 2010-05-19 | Nutraceuticals Ltd | Compositions comprising polyunsaturated fatty acids |
CN101663031A (zh) * | 2007-02-20 | 2010-03-03 | 马泰克生物科学公司 | 来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法 |
CA2688293A1 (fr) * | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Formulations de regime et procedes de traitement d'une inflammation et d'autres troubles |
CN101820754A (zh) * | 2007-10-04 | 2010-09-01 | 雀巢产品技术援助有限公司 | 用于增强认知功能的组合物与方法 |
EP2230944B1 (fr) * | 2007-11-29 | 2017-01-04 | Monsanto Technology, LLC | Produits carnés dont les niveaux d'acides gras bénéfiques ont été augmentés |
WO2009086281A1 (fr) * | 2007-12-21 | 2009-07-09 | Martek Biosciences Corporation | Procédé de préparation d'oxylipines |
US20100266746A1 (en) * | 2009-04-16 | 2010-10-21 | Monsanto Technology Llc | Spread formulations including stearidonic acid |
CN102469826A (zh) * | 2009-07-15 | 2012-05-23 | 索莱有限责任公司 | 富含ω-3脂肪酸的汤和调味料 |
IN2012DN02228A (fr) * | 2009-09-30 | 2015-08-21 | Solae Llc | |
WO2011071365A1 (fr) * | 2009-12-07 | 2011-06-16 | N.V. Nutricia | Composition lipidique équilibrée et son utilisation dans une composition nutritionnelle liquide adaptée à l'alimentation entérale |
WO2011091019A1 (fr) * | 2010-01-19 | 2011-07-28 | University Of Tennessee Research Foundation | Procédés et compositions pour traiter et prévenir une maladie hépatique associée à la nutrition parentérale |
US8372465B2 (en) * | 2010-02-17 | 2013-02-12 | Bunge Oils, Inc. | Oil compositions of stearidonic acid |
CA2820960A1 (fr) | 2010-12-29 | 2012-07-05 | Abbott Laboratories | Produits nutritionnels contenant un nouveau systeme lipidique contenant des monoglycerides |
US20120252888A1 (en) | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
WO2012138212A1 (fr) | 2011-04-06 | 2012-10-11 | N.V. Nutricia | Composition alimentaire pour une alimentation par tube intra-opératoire |
US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
US20150157048A1 (en) * | 2013-12-11 | 2015-06-11 | Mead Johnson Nutrition Company | Nutritional compositions containing stearidonic acid and uses thereof |
US11419350B2 (en) | 2016-07-01 | 2022-08-23 | Corbion Biotech, Inc. | Feed ingredients comprising lysed microbial cells |
CN109527123A (zh) * | 2018-12-14 | 2019-03-29 | 大连大学 | 一种对慢性肠炎具有改善作用的调和油 |
CN112891304B (zh) * | 2020-10-14 | 2022-06-10 | 麦孚营养科技有限公司 | 一种高能量密度的脂肪乳剂及其制备方法和其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3924607A1 (de) * | 1989-07-21 | 1991-01-24 | Singer Peter Dr Sc Med | Diaetetisches nahrungs- oder genussmittel |
DE69004081T2 (de) * | 1990-05-23 | 1994-02-10 | Nestle Sa | Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen. |
GB9026648D0 (en) * | 1990-12-07 | 1991-01-23 | Efamol Holdings | Nutrition |
US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
CA2119000A1 (fr) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation pour fumeurs |
US5714472A (en) * | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
DE19528461A1 (de) * | 1995-08-03 | 1997-02-06 | Braun Melsungen Ag | Präparat zur Ernährung |
ES2463815T3 (es) * | 1996-03-26 | 2014-05-29 | Dsm Ip Assets B.V. | Agregado tardío de pufa en el transcurso del proceso de preparación de una leche maternizada |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
-
1997
- 1997-12-23 DE DE19757414A patent/DE19757414A1/de not_active Withdrawn
-
1998
- 1998-12-22 ES ES98966662T patent/ES2173673T3/es not_active Expired - Lifetime
- 1998-12-22 WO PCT/EP1998/008409 patent/WO1999033355A2/fr active IP Right Grant
- 1998-12-22 EP EP98966662A patent/EP1041896B1/fr not_active Expired - Lifetime
- 1998-12-22 BR BR9814467-7A patent/BR9814467A/pt not_active Application Discontinuation
- 1998-12-22 DK DK98966662T patent/DK1041896T3/da active
- 1998-12-22 NZ NZ505608A patent/NZ505608A/xx not_active IP Right Cessation
- 1998-12-22 CN CN98812474A patent/CN1091363C/zh not_active Expired - Fee Related
- 1998-12-22 JP JP2000526127A patent/JP2001526908A/ja active Pending
- 1998-12-22 CA CA002316298A patent/CA2316298C/fr not_active Expired - Fee Related
- 1998-12-22 AT AT98966662T patent/ATE213391T1/de active
- 1998-12-22 AU AU24162/99A patent/AU758079B2/en not_active Ceased
- 1998-12-22 US US09/581,520 patent/US7045143B1/en not_active Expired - Fee Related
- 1998-12-22 DE DE59803153T patent/DE59803153D1/de not_active Expired - Lifetime
-
2000
- 2000-06-22 NO NO20003265A patent/NO316302B1/no not_active IP Right Cessation
-
2001
- 2001-04-11 HK HK01102614A patent/HK1033541A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2316298A1 (fr) | 1999-07-08 |
CA2316298C (fr) | 2008-11-18 |
EP1041896A2 (fr) | 2000-10-11 |
JP2001526908A (ja) | 2001-12-25 |
DE59803153D1 (de) | 2002-03-28 |
ES2173673T3 (es) | 2002-10-16 |
NO20003265D0 (no) | 2000-06-22 |
AU2416299A (en) | 1999-07-19 |
AU758079B2 (en) | 2003-03-13 |
WO1999033355A2 (fr) | 1999-07-08 |
ATE213391T1 (de) | 2002-03-15 |
CN1091363C (zh) | 2002-09-25 |
BR9814467A (pt) | 2000-10-10 |
NO316302B1 (no) | 2004-01-12 |
NZ505608A (en) | 2002-12-20 |
CN1282223A (zh) | 2001-01-31 |
DE19757414A1 (de) | 1999-07-01 |
US7045143B1 (en) | 2006-05-16 |
HK1033541A1 (en) | 2001-09-07 |
EP1041896B1 (fr) | 2002-02-20 |
WO1999033355A3 (fr) | 1999-09-16 |
NO20003265L (no) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1041896T3 (da) | Fedtblanding | |
DK1121115T4 (da) | PUFA-tilskud | |
DiGiacomo et al. | Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study | |
Nordström et al. | Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed | |
EP1296670B1 (fr) | Combinaisons therapeutiques d'acides gras | |
SG64864A1 (en) | Phospholipids | |
EP0815735A3 (fr) | Produit laitier diététiquement équilibré | |
KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
JPH08500332A (ja) | 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用 | |
DK563388A (da) | Isoton omega-3-fedtsyreholdig fedtemulsion og fremgangsmaaden til fremstilling deraf | |
WO2008147562A3 (fr) | Formulations de régime et procédés de traitement d'une inflammation et d'autres troubles | |
JPH0716076A (ja) | 喫煙者のための調製物 | |
IT8423086A1 (it) | Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica | |
CN103002889A (zh) | Sn-2-单酰基甘油和脂质吸收不良 | |
Peck | Essential fatty acid deficiency in renal failure: can supplements really help? | |
AU1489688A (en) | Omega-3 fatty acids in traumatic injury treatment | |
Darlington | Do diets rich in polyunsaturated fatty acids affect disease activity in rheumatoid arthritis? | |
JP2537645B2 (ja) | 薬剤的活性を有する栄養組成物 | |
Ling et al. | Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet | |
CA1334002C (fr) | Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferes | |
Tamargo et al. | Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids | |
Maki et al. | Bioavailability of eicosapentaenoic and docosahexaenoic n‐3 polyunsaturated fatty acids in salmon patties compared with capsules | |
Olafsson et al. | Dietary cod liver oil decreases arachidonic acid in rat gastric mucosa and increases stress-induced gastric erosions | |
Llor et al. | The effect of olive oil on inflammatory bowel disease. | |
Houston | The Use of Fish Oil Supplements in Clinical Practice: A Review |